Julie O'Neill is EVP. Global Operations at ALEXION PHARMACEUTICALS INC (ALXN). They have made 14 open-market trades across 2 companies since 2015, most recently 2026-08-11.
CIK 0001630299
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 51,727 | $9.4M |
| ICLR | 3,515 | $598K |
| HOOK | 4,969 | $4K |
| Total | $10.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICLR | SELL | 2026-08-11 | 2026-08-12 | $164.29 | $150K | +3.8% | +1.2% | — |
| ALXN | SELL | 2018-02-27 | 2018-03-01 | $119.83 | $195K | +5.6% | -5.3% | +1.5% |
| ALXN | SELL | 2018-02-08 | 2018-02-08 | $116.31 | $557K | +7.4% | +16.5% | +7.1% |
| ALXN | SELL | 2018-02-05 | 2018-02-07 | $117.26 | $248K | +2.2% | +8.1% | -1.2% |
| ALXN | SELL · 10b5-1 | 2017-08-31 | 2017-09-05 | $145.44 | $636K | +1.1% | -0.9% | -23.0% |
| ALXN | SELL · 10b5-1 | 2017-08-28 | 2017-08-30 | $140.00 | $1.6M | +3.8% | +1.1% | -22.1% |
| ALXN | SELL | 2017-03-02 | 2017-03-06 | $133.80 | $87K | -7.5% | -12.2% | -23.2% |
| ALXN | SELL | 2017-02-27 | 2017-03-01 | $131.41 | $207K | -6.7% | -9.4% | -26.9% |
| ALXN | SELL | 2017-02-06 | 2017-02-08 | $125.69 | $351K | +2.4% | +0.4% | -1.7% |
| ALXN | SELL | 2016-09-02 | 2016-09-02 | $126.29 | $82K | +4.8% | -1.3% | -1.4% |
| ALXN | SELL | 2016-03-02 | 2016-03-04 | $149.55 | $97K | -8.6% | +2.8% | +9.5% |
| ALXN | SELL | 2016-02-29 | 2016-03-01 | $138.91 | $92K | -6.9% | -6.9% | +0.9% |
| ALXN | SELL | 2016-02-05 | 2016-02-08 | $141.83 | $405K | +6.5% | +2.6% | +4.8% |
| ALXN | SELL | 2015-09-02 | 2015-09-10 | $171.76 | $111K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2015-03-02 | 2015-03-03 | $180.34 | $1.2M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2015-02-10 | 2015-02-12 | $171.15 | $136K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.